Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations

Overview of attention for article published in Osteopathic Medicine and Primary Care, October 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 42 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

NICE Recommends Astellas’ EVRENZO▼™ (roxadustat) For Adults With Symptomatic Anaemia Associated With Chronic Kidney Disease

PharmiWeb, 10 Jun 2022

EVRENZOTM (roxadustat) is the first hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor to be recommended by NICE1…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.